{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:46:35Z","timestamp":1792525595492,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1053\/j.akdh.2024.04.005","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T16:03:03Z","timestamp":1720800183000},"page":"194-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["ANCA-Associated Vasculitis"],"prefix":"10.1053","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2106-7100","authenticated-orcid":false,"given":"Purva","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7389-4549","authenticated-orcid":false,"given":"Reza","family":"Zonozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duvuru","family":"Geetha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1053\/j.akdh.2024.04.005_bib2","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1093\/ndt\/gfn354","article-title":"Renal vasculitis in Japan and the UK--are there differences in epidemiology and clinical phenotype?","volume":"23","author":"Watts","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.akdh.2024.04.005_bib3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/rheumatology\/ken079","article-title":"Evaluation of a new algorithm in classification of systemic vasculitis","volume":"47","author":"Liu","year":"2008","journal-title":"Rheumatology"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.20077","article-title":"Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener\u2019s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate","volume":"51","author":"Mahr","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"Suppl 3","key":"10.1053\/j.akdh.2024.04.005_bib5","doi-asserted-by":"crossref","first-page":"iii42","DOI":"10.1093\/rheumatology\/keaa089","article-title":"An update on the epidemiology of ANCA-associated vasculitis","volume":"59","author":"Mohammad","year":"2020","journal-title":"Rheumatology"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjmed.2004.02.030","article-title":"The antineutrophil cytoplasmic antibody-associated vasculitides","volume":"117","author":"Seo","year":"2004","journal-title":"Am J Med"},{"issue":"21","key":"10.1053\/j.akdh.2024.04.005_bib7","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJM199711203372106","article-title":"Small-vessel vasculitis","volume":"337","author":"Jennette","year":"1997","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.005_bib8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1681\/ASN.2010101058","article-title":"DRB1\u221715 allele is a risk factor for PR3-ANCA disease in African Americans","volume":"22","author":"Cao","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2024.04.005_bib9","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1136\/annrheumdis-2015-207601","article-title":"Genetic variants in ANCA-associated vasculitis: a meta-analysis","volume":"75","author":"Rahmattulla","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1053\/j.akdh.2024.04.005_bib10","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/rheumatology\/ker454","article-title":"The contrasting epidemiology of granulomatosis with polyangiitis (Wegener\u2019s) and microscopic polyangiitis","volume":"51","author":"Watts","year":"2012","journal-title":"Rheumatology"},{"issue":"4","key":"10.1053\/j.akdh.2024.04.005_bib11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/ckj\/sfx127","article-title":"Seasonal variations in the onset of positive and negative renal ANCA-associated vasculitis in Spain","volume":"11","author":"Draibe","year":"2018","journal-title":"Clin Kidney J"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann Intern Med"},{"issue":"1 Suppl 57","key":"10.1053\/j.akdh.2024.04.005_bib13","first-page":"51","article-title":"Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic Rhinosinusitis with nasal polyps","volume":"28","author":"Laudien","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.005_bib14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/art.10830","article-title":"Are environmental factors important in primary systemic vasculitis? A case-control study","volume":"48","author":"Lane","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1053\/j.akdh.2024.04.005_bib15","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/ndt\/10.7.1162","article-title":"Wegener granulomatosis is associated to exposure to silicon compounds: a case-control study","volume":"10","author":"Nuyts","year":"1995","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.005_bib16","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamainternmed.2020.0675","article-title":"Association of cigarette smoking with antineutrophil cytoplasmic antibody\u2013associated vasculitis","volume":"180","author":"McDermott","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1053\/j.akdh.2024.04.005_bib17","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.2215\/CJN.00360114","article-title":"Nephrotoxic effects of common and emerging drugs of abuse","volume":"9","author":"Pendergraft","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/BOR.0000000000000014","article-title":"Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis","volume":"26","author":"Pendergraft","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1053\/j.akdh.2024.04.005_bib19","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/1529-0131(200011)43:11<2488::AID-ANR16>3.0.CO;2-X","article-title":"Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine","volume":"43","author":"Choi","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.005_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5","article-title":"Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies","volume":"43","author":"Choi","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1053\/j.akdh.2024.04.005_bib21","first-page":"1925","article-title":"Goodpasture-like syndrome associated with anti-myeloperoxidase antibodies following penicillamine treatment","volume":"10","author":"Gaskin","year":"1995","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.005_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00000441-200012000-00008","article-title":"Rapidly progressive glomerulonephritis with D-penicillamine","volume":"320","author":"Nanke","year":"2000","journal-title":"Am J Med Sci"},{"issue":"5","key":"10.1053\/j.akdh.2024.04.005_bib23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.ajkd.2007.05.026","article-title":"D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease","volume":"50","author":"Bienaim\u00e9","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.005_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1081\/JDI-100100869","article-title":"Cephotaxime-associated allergic interstitial nephritis and MPO-ANCA positive vasculitis","volume":"22","author":"Feriozzi","year":"2000","journal-title":"Ren Fail"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/art.41902","article-title":"A worldwide pharmacoepidemiologic update on drug-induced antineutrophil cytoplasmic antibody-associated vasculitis in the Era of Targeted Therapies","volume":"74","author":"Deshayes","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1053\/j.akdh.2024.04.005_bib26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1310\/hpx5204-294","article-title":"Anti-nuclear cytoplasmic antibody-associated vasculitis: a probable adverse effect of sofosbuvir treatment in chronic hepatitis C patients","volume":"52","author":"Ahmad","year":"2017","journal-title":"Hosp Pharm"},{"issue":"4","key":"10.1053\/j.akdh.2024.04.005_bib27","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1172\/JCI65292","article-title":"Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis","volume":"123","author":"Roth","year":"2013","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.akdh.2024.04.005_bib28","first-page":"242","article-title":"Epitope analysis of myeloperoxidase (MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis","volume":"53","author":"Fujii","year":"2000","journal-title":"Clin Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2024.04.005_bib29","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/sj.ki.5000354","article-title":"Mapping of myeloperoxidase epitopes recognized by MPO-ANCA using human-mouse MPO chimers","volume":"69","author":"Erdbr\u00fcgger","year":"2006","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.005_bib31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/annrheumdis-2021-221796","article-title":"2022 American College of Rheumatology\/European Alliance of associations for Rheumatology classification criteria for microscopic polyangiitis","volume":"81","author":"Suppiah","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.005_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/annrheumdis-2021-221795","article-title":"2022 American college of Rheumatology\/European Alliance of associations for Rheumatology classification criteria for granulomatosis with polyangiitis","volume":"81","author":"Robson","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.005_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"2022 American college of Rheumatology\/European Alliance of associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.005_bib34","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1111\/j.1523-1755.2004.00632.x","article-title":"Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases","volume":"65","author":"Haas","year":"2004","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2024.04.005_bib35","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1523-1755.2004.00917.x","article-title":"Clinical features and outcome of patients with both ANCA and anti-GBM antibodies","volume":"66","author":"Levy","year":"2004","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.005_bib36","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.kint.2017.03.014","article-title":"Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients","volume":"92","author":"McAdoo","year":"2017","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.005_bib37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2013111233","article-title":"ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease","volume":"26","author":"Kemna","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13075-017-1321-1","article-title":"Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse","volume":"19","author":"Morgan","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1523-1755.2002.00089.x","article-title":"Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups","volume":"61","author":"Hauer","year":"2002","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.005_bib40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2215\/CJN.04060808","article-title":"Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis","volume":"4","author":"Nasr","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2024.04.005_bib41","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/ndt\/12.5.1017","article-title":"Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases","volume":"12","author":"Tse","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1053\/j.akdh.2024.04.005_bib42","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1191\/0961203303lu456rr","article-title":"Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus","volume":"12","author":"Sen","year":"2003","journal-title":"Lupus"},{"key":"10.1053\/j.akdh.2024.04.005_bib43","article-title":"Fibrillary Glomerulopathy with a high level of myeloperoxidase-ANCA: a case report","volume":"2020","author":"Asakawa","year":"2020","journal-title":"Case Rep Nephrol Urol"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0272-6386(12)80171-5","article-title":"The pathology of vasculitis involving the kidney","volume":"24","author":"Jennette","year":"1994","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib45","first-page":"185","article-title":"Azathioprine induced acute interstitial nephritis as the cause of rapidly progressive renal failure in a patient with Wegener\u2019s granulomatosis","volume":"33","author":"Bir","year":"2006","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1053\/j.akdh.2024.04.005_bib46","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/art.39614","article-title":"Trends in long-term outcomes among patients with antineutrophil cytoplasmic antibody-associated vasculitis with renal disease","volume":"68","author":"Rhee","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.005_bib47","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/acr.22976","article-title":"Nationwide Trends in Hospitalizations and in-Hospital mortality in granulomatosis with polyangiitis (Wegener\u2019s)","volume":"69","author":"Wallace","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"9","key":"10.1053\/j.akdh.2024.04.005_bib48","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2016-210942","article-title":"Mortality in ANCA-associated vasculitis: ameta-analysis of observational studies","volume":"76","author":"Tan","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.berh.2018.07.009","article-title":"The complications of vasculitis and its treatment","volume":"32","author":"King","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"9","key":"10.1053\/j.akdh.2024.04.005_bib50","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3899\/jrheum.131426","article-title":"Predictors for mortality in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: a study of 398 Chinese patients","volume":"41","author":"Lai","year":"2014","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","article-title":"Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.005_bib52","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ki.2009.218","article-title":"The clinical course of ANCA small-vessel vasculitis on chronic dialysis","volume":"76","author":"Lionaki","year":"2009","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.005_bib53","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1523-1755.2003.00769.x","article-title":"Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement","volume":"63","author":"Slot","year":"2003","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.akdh.2024.04.005_bib54","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2215\/CJN.01020113","article-title":"Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis","volume":"8","author":"de Joode","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.005_bib55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3899\/jrheum.190065","article-title":"Prevalence and risk factors for major infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis: influence on the disease outcome","volume":"47","author":"Garcia-Vives","year":"2020","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.005_bib56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.005_bib57","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1053\/j.akdh.2024.04.005_bib58","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-143-9-200511010-00005","article-title":"Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis","volume":"143","author":"Hogan","year":"2005","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.akdh.2024.04.005_bib59","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1046\/j.1523-1755.2002.00605.x","article-title":"Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients","volume":"62","author":"Hauer","year":"2002","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib60","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ndt\/gfh563","article-title":"Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis","volume":"20","author":"Neumann","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.005_bib61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1681\/ASN.2011040330","article-title":"Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy","volume":"23","author":"Berden","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.akdh.2024.04.005_bib62","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1002\/art.39317","article-title":"Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013","volume":"67","author":"Rahmattulla","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1053\/j.akdh.2024.04.005_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126016","article-title":"Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies","volume":"10","author":"Shang","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.005_bib64","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/annrheumdis-2016-209925","article-title":"Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis","volume":"76","author":"van Daalen","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1053\/j.akdh.2024.04.005_bib65","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/ckj\/sfac009","article-title":"Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?","volume":"15","author":"Floyd","year":"2022","journal-title":"Clin Kidney J"},{"issue":"7","key":"10.1053\/j.akdh.2024.04.005_bib66","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-Associated Vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1053\/j.akdh.2024.04.005_bib67","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1001\/jama.2021.6615","article-title":"Effect of reduced-dose vs high-dose glucocorticoids added to rituximab on remission induction in ANCA-Associated vasculitis: a randomized clinical trial","volume":"325","author":"Furuta","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.005_bib68","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.005_bib69","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1053\/j.akdh.2024.04.005_bib70","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.005_bib71","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up","volume":"71","author":"Harper","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.005_bib72","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/annrheumdis-2015-208073","article-title":"Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type","volume":"75","author":"Unizony","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.005_bib73","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ekir.2017.11.004","article-title":"Combination therapy with rituximab and cyclophosphamide for remission induction in ANCA vasculitis","volume":"3","author":"Cortazar","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.005_bib74","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.kint.2021.08.025","article-title":"Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis","volume":"100","author":"Gulati","year":"2021","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.akdh.2024.04.005_bib75","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2215\/CJN.11801018","article-title":"Mycophenolate mofetil Versus cyclophosphamide for the induction of remission in nonlife-threatening relapses of antineutrophil cytoplasmic antibody-associated vasculitis: randomized, controlled trial","volume":"14","author":"Tuin","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.005_bib76","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/annrheumdis-2018-214245","article-title":"Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial","volume":"78","author":"Jones","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1053\/j.akdh.2024.04.005_bib77","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/ndt\/gfab357","article-title":"Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis","volume":"37","author":"Berti","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.akdh.2024.04.005_bib78","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1053\/j.akdh.2024.04.005_bib79","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the Treatment of ANCA-Associated Vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.akdh.2024.04.005_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.ekir.2024.03.022","article-title":"Real-world experience with avacopan in antineutrophil cytoplasmic autoantibody-associated vasculitis","author":"Zonozi","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"7","key":"10.1053\/j.akdh.2024.04.005_bib81","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.akdh.2024.04.005_bib82","article-title":"The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis","volume":"376","author":"Walsh","year":"2022","journal-title":"BMJ"},{"issue":"19","key":"10.1053\/j.akdh.2024.04.005_bib83","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1053\/j.akdh.2024.04.005_bib84","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/annrheumdis-2017-212878","article-title":"Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)","volume":"77","author":"Charles","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.005_bib85","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/M19-3827","article-title":"Long-term rituximab use to maintain remission of antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"173","author":"Charles","year":"2020","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.005_bib86","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard-2023-224489","article-title":"Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial","volume":"83","author":"Zonozi","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1053\/j.akdh.2024.04.005_bib87","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/ard-2022-223559","article-title":"Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial","volume":"82","author":"Smith","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1053\/j.akdh.2024.04.005_bib88","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/annrheumdis-2017-211123","article-title":"Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis","volume":"76","author":"Karras","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"26","key":"10.1053\/j.akdh.2024.04.005_bib89","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1053\/j.akdh.2024.04.005_bib90","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","article-title":"Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial","volume":"304","author":"Hiemstra","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.005_bib91","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar1957","article-title":"Anti-inflammatory and immunosuppressive drugs and reproduction","volume":"8","author":"\u00d8stensen","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1053\/j.akdh.2024.04.005_bib92","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000734","article-title":"and pregnancy","volume":"7","author":"Smith","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.005_bib93","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1212\/NXI.0000000000000453","article-title":"Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD","volume":"5","author":"Das","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.005_bib94","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/RHU.0b013e31816b2fbd","article-title":"ANCA vasculitis in the elderly","volume":"14","author":"Hoganson","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"10.1053\/j.akdh.2024.04.005_bib95","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-023-06644-2","article-title":"Outcomes of remission induction therapy for ANCA-associated vasculitis in the elderly","author":"Aqeel","year":"2023","journal-title":"Clin Rheumatol"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294981392400079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294981392400079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T19:04:20Z","timestamp":1720811060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S294981392400079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S294981392400079X"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2024.04.005","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ANCA-Associated Vasculitis","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2024.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the National Kidney Foundation, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}